Articles

Approach may boost success of stem cell transplants

Researchers at the Indiana University School of Medicine found that blocking the activity of a key protein can significantly cut down on the graft-versus-host immune response suffered by large numbers of patients who receive stem cell transplants.

Read More

Surge of new customers boosts Anthem’s profit

Anthem’s third-quarter profit rose nearly 4 percent as it added 174,000 health plan members. Its Medicaid, local employer and national employer segments all grew, although its individual business saw losses.

Read More

Lilly CEO: Drugmakers getting bum rap

Eli Lilly and Co. CEO John Lechleiter told Wall Street analysts recently that, while there have been “individual huge drug price increases,” the overall cost of drugs is rising very slowly and remains a small part of overall U.S. health care spending.

Read More